CASI Pharmaceuticals annual revenue
2020
2021
2022
2023
2024
2025
CASI Pharmaceuticals Revenue Growth & History (CASIF)
CASI Pharmaceuticals reported $20.7M in revenue for fiscal 2025, a decrease of 27.42% from the previous fiscal year.
View full CASI Pharmaceuticals company overviewCASI Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.7M | −$7.8M | −27.42% |
| 2024 | 2024-12-31 | $28.5M | −$5.3M | −15.77% |
| 2023 | 2023-12-31 | $33.9M | −$4.2M | −10.95% |
| 2022 | 2022-12-31 | $38.0M | $8.0M | +26.74% |
| 2021 | 2021-12-31 | $30.0M | $15.0M | +100.12% |
| 2020 | 2020-12-31 | $15.0M | — | — |
CASI Pharmaceuticals quarterly revenue
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $7.2M | −$6.1M | −45.93% |
| Q3 2025 | 2025-09-30 | $3.1M | — | — |
| Q2 2025 | 2025-06-30 | $4.2M | — | — |
| Q1 2025 | 2025-03-31 | $6.2M | — | — |
| Q4 2024 | 2024-12-31 | $13.4M | — | — |
CASI Pharmaceuticals revenue growth trends
Over the last five reported fiscal years, revenue grew from $15.0M to $20.7M, a compound annual growth rate of 6.66%. CASI Pharmaceuticals's latest reported quarter, Q4 2025, generated $7.2M in revenue, a decrease of 45.93% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review CASI Pharmaceuticals source filings ↗